FDA Inspection 953823 — Temmler Pharma GmbH & Co. KG

Temmler Pharma GmbH & Co. KG — FEI 3002808339

The FDA completed an inspection of Temmler Pharma GmbH & Co. KG on December 4, 2015 in Marburg. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
December 4, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Marburg (Germany)

Citations

IDCFRDescription
180121 CFR 211.84(a)Components withheld from use pending release
188521 CFR 211.165(b)Microbiological testing
436421 CFR 211.176Failing to test for penicillin cross-contamination